Search Results 71-80 of 16760 for CLL

  1. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...

  2. Study to Evaluate Safety and Preliminary Efficacy of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS) - Mayo Clinic

    About this study. This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or venetoclax in adult patients with R/R CLL or ...

  3. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  4. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (IWCLL) criteria and having received at least 2 prior treatment regimens; CLL that warrants treatment; Clinically quantifiable ...

  5. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    AXL was identified as a potential therapeutic target in chronic lymphocytic leukemia (CLL). TP 0903 was shown to induce apoptosis in CLL B-cells taken directly ...

  6. Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL). Print ... Cohort 4 only: Previously treated subjects with active CLL/SLL with ...

  7. Lindsey E. Roeker, M.D. - Doctors and Medical Staff - Mayo Clinic

    Lindsey Roeker, M.D., is a board-certified hematologist / oncologist and clinical researcher focusing on chronic lymphocytic leukemia (CLL) and Richter's ...

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...

  9. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small ...

  10. Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia (B-CLL). Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells ...